The company now provides specifications for numerous manufacturing toxins and a lesser-known omega-3 fatty acid.
EPAX AS (Oslo, Norway) is making available a variety of new specifications relating to potential processing toxins and nutritional values for its fish oil concentrates.
Under the company’s new standards, brominated flame retardants, dioxins, and furans will be measured for all batches of processed fish oil.
“To have a pure product is very important for consumer safety, and we take this very seriously,” said Gunilla Traberg, EPAX head of marketing. “We continue to review our max limits for these and other compounds because we want to continue to beat our own limits. You have established maximum standards that may be regulated in the United States by the GOED Voluntary Monograph or in Europe by the European Pharmacopeia. We make sure to fall below these standards and also beat our own max limits when it comes to true values that we produce. We added these new values into our specifications as a service to our customers or because these specifications will show up in the regulations in the future.”
EPAX is also now measuring for levels of the lesser omega-3 fatty acid docosapentaenoic acid (DPA).
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.